While phenotypically the family resembled exertion-related CPVT1, we speculated that the underlying pathology was different mechanistically and may represent a novel loss of function of RyR2, which we referred to as calcium release channel deficiency syndrome. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia 1.